• Illumina at JPM: Multi-Omics, Constellation, Partnerships

    Jan 16 | Bio-IT World | Jacob Thaysen gave Illumina’s annual presentation at the 43rd Annual J.P. Morgan Healthcare Conference yesterday, outlining Illumina’s early 2024 results and the vision for the future. Illumina is not focusing only on building sequencers and sequencing genomes. Thaysen outlined an M&A and partnership strategy focused on expanding the company’s addressable markets. More

  • Oxford Nanopore at JPM: A Proteomics-Genomics Thing of Beauty

    Jan 15 | Bio-IT World | Gordon Sanghera, CEO, presented on behalf of Oxford Nanopore Technologies at the 43rd Annual J.P. Morgan Healthcare Conference this week in San Francisco. Sanghera led the major sequencing companies in position on the program, presenting on Monday a multi-omics and proteomics emphasis that was echoed throughout the week by other sequencing platform providers. More

  • Exploring Muscle Clues in Chronic Fatigue Syndrome and Long COVID

    Jan 14 | Bio-IT World | An international team of researchers is delving into the molecular and cellular changes in muscle tissue associated with Chronic Fatigue Syndrome (CFS) and long COVID. The effort focuses on identifying biomarkers and pathways that could pave the way for diagnosis and treatment. More

  • Illumina Joins NVIDIA’s Agentic AI Vision at J.P. Morgan Healthcare Conference

    Jan 13 | Bio-IT World | Among the many partnerships and technical announcements made by NVIDIA during the company's Monday morning presentation at the 43rd Annual J.P. Morgan Healthcare Conference, NVIDIA focused several on innovation within the healthcare and life sciences industry. More

  • Many Looming Unknowns About AI Policies of Incoming Administration

    Jan 09 | Bio-IT World | Looming uncertainties tied to the upcoming U.S. administration change will affect many key areas of artificial intelligence (AI) in 2025, according to Mark Dredze, interim deputy director for the Data Science and AI Institute at Johns Hopkins University. While a focus on deregulation appears likely, exactly how things will play out for AI governance and policy is anyone’s guess. More

  • Medicines for Placental Disorders Working Their Way up the Species Ladder

    Jan 08 | Bio-IT World | The placenta is a temporary but critical organ everyone needs to initiate their life, yet it remains one of the most understudied organs in human biology despite the possible lifelong health implications if anything it is supposed to do goes awry. More

  • Trendspotting: Predictions for Bio-IT World in 2025

    Jan 07 | Bio-IT World | 2024 was full of innovative ideas and achievements. We spoke with industry experts and leaders about what to anticipate in the new year. Here are the full trends and predictions, including more on AI/ML, multimodal data, drug discovery, new policies, spatial biology, and more. More

  • Top Stories of 2024: Illumina, Pistoia Alliance, Generative AI, Sequencing, More

    Jan 03 | Bio-IT World | Last year, the world of biotech achieved much with AI, sequencing, treatment development, and more. The Trends from the Trenches podcast also covered data management strategies, embracing change, and the technologies driving data-intensive science. To kick off the new year, here are the top stories and top podcast episodes of 2024 from Bio-IT World and Trends from the Trenches. More

  • AI Can’t Fix Bad Data: Why Semantic Technologies Are Key to R&D Acceleration

    Dec 30 | Bio-IT World | What role will AI play in the future of drug development, especially as novel therapeutic approaches such as precision medicine drive up the complexity and cost of research? Some industry headlines hype AI as a magic bullet, capable of cutting through the headwinds of slow development cycles, shifting regulations, and high rates of failure. For companies racing to reach the market with safe and compliant new drug products, this vision of AI is compelling—and it’s driving heavy investment. More

  • BC Platform, University of Nottingham Partnership, Certis Oncology Launches AI Assistant, More

    Dec 27 | Bio-IT World | BC Platforms enters an extended joint partnership with the University of Nottingham and Nottingham University Hospitals NHS Trust to provide data sharing platforms and tools; Certis Oncology Solutions launches CertisOI Assistant, an innovative chatbot tool ; and more. More
View more articles
Bio IT World Lead Gen

 
Industry-spotlight

Riffyn’s pioneering cloud system, Riffyn Nexus, delivers 2X faster development cycles and 4X productivity gains to the world’s most advanced scientific R&D organizations. Its process-centric experiment design, data capture, and data analytics overcome the limitations of ELN and LIMS systems. Its adaptive data integration engine delivers results that are always ready for machine learning.
Read more here!

Industry-spotlight
Trends from the Trenches

Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders. BioTeam co-founder Stan Gloss brings years of industry experience in science, data, and technology to conversations exploring what is driving data and discovery, and what’s coming next.
Listen today!